Date: May 27, 2021

Quarter: Thursday Q4

Minutes Approved as Presented 

This is to approve minutes via general consent. "You have received the minutes. Are there any corrections to the minutes? (pause) Hearing none, if there are no objections, the minutes are approved as printed."


Set goals, objectives or some context for this meeting.

Discussion items


ADE Ballot ReconSarah Gaunt
  • Adverse Drug Event FHIR IG
  • Balloted in May 2021
  • 31 affirmative/0 Negative/58 Abstain/16 No Vote
  • Jean Duteau will be uploading comments to Jira
  • Comments 1 and 2 (Spreadsheet)
    • Question about the use of Example as the binding strength for some value sets
      • Many of these may be inherited from the parent resource being profiled by the IG
      • There may be a problem with how the IG Publisher is displaying fixed codes (patterns) for data elements
      • No changes are required to the content of the IG, only the presentation of the requirements
    • Motion to Persuasive with Mod and follow up with the IG Publisher group to address the display issue (Sarah Gaunt/AbdulMalik Shakir 8-0-1)
  • Comment 9 (Spreadsheet)
    • Suggestion to add an additional related standard
    • Motion to find Persuasive and add the suggested related standard (Sarah Gaunt/Craig Newman 9-0-0)
  • Comment 10 (Spreadsheet)
    • Suggestion to consider a generic Measure IG rather than a whole IG
      • Might fit into a SANER type framework
    • It's too late in the process to make this change now, but will be discussed with the project sponsor about pursuing in the future
    • Motion to find as Considered for Future Use (Sarah Gaunt/AbdulMalik Shakir 10-0-0)
  • Comment FHIR-32029
    • Suggests requiring an identifier for each Composition to distinguish updates from new reports
    • Persuasive - .identifier will be updated to be required
  • Comment FHIR-32038
    • Asks for guidance on populating the sections of the Composition
    • Persuasive - narrative will be added
  • Comment FHIR-32027
    • Asks for guidance on populating the sections of the Composition
    • Persuasive - narrative will be added
  • Comment FHIR-32026
    • Suggestion to clarify the scope of the IG as being limited to hypoglycemia
    • Persuasive with Mod- will update as suggested and author will check to make sure there are no other places where similar clarification is needed
  • Comment FHIR-32025
    • Suggests clarifying the scope of the IG
    • Persuasive - will update to clarify the scenarios
  • Motion to approve comments FHIR-32025, FHIR-32026, FHIR-32027, FHIR-32028, and FHIR-32029 as documented above (Sarah Gaunt/Craig Newman 10-0-0)
  • FHIR-32030 needs further discussion with project SMEs

Action items